ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $256,823 | +1.0% | 9,558 | -4.6% | 0.00% | 0.0% |
| Q1 2023 | $254,356 | -46.2% | 10,014 | -14.2% | 0.00% | -50.0% |
| Q4 2022 | $473,214 | +18.6% | 11,667 | -3.4% | 0.01% | +14.3% |
| Q3 2022 | $399,000 | +16.7% | 12,076 | +24.4% | 0.01% | +16.7% |
| Q2 2022 | $342,000 | -20.6% | 9,704 | +3.5% | 0.01% | -14.3% |
| Q1 2022 | $431,000 | -10.2% | 9,378 | +29.5% | 0.01% | -22.2% |
| Q4 2021 | $480,000 | +27.0% | 7,244 | +19.9% | 0.01% | +12.5% |
| Q3 2021 | $378,000 | -30.5% | 6,040 | -8.1% | 0.01% | -27.3% |
| Q2 2021 | $544,000 | +25.1% | 6,572 | 0.0% | 0.01% | +10.0% |
| Q1 2021 | $435,000 | -15.0% | 6,572 | -1.5% | 0.01% | -28.6% |
| Q4 2020 | $512,000 | +1.6% | 6,675 | -42.8% | 0.01% | -6.7% |
| Q3 2020 | $504,000 | -9.2% | 11,670 | -9.1% | 0.02% | -11.8% |
| Q2 2020 | $555,000 | +22.0% | 12,845 | -18.4% | 0.02% | +6.2% |
| Q1 2020 | $455,000 | -49.9% | 15,742 | +9.6% | 0.02% | -20.0% |
| Q4 2019 | $909,000 | +30200.0% | 14,359 | +5833.5% | 0.02% | – |
| Q4 2018 | $3,000 | – | 242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |